Hanson & Doremus Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Hanson & Doremus Investment Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Hold	15,161	–	–	0.02%	198
2026 Q1	$210K	Hold	15,161	–	–	0.02%	193
2025 Q4	$213K	Hold	15,161	–	–	0.03%	193
2025 Q3	$212K	Hold	15,161	–	–	0.03%	197
2025 Q2	$228K	Sell	15,161 -695	-4%	-$9.93K	0.03%	188
2025 Q1	$209K	Sell	15,856 -7,314	-32%	-$101K	0.03%	188
2024 Q4	$366K	Hold	23,170	–	–	0.06%	133
2024 Q3	$368K	Hold	23,170	–	–	0.06%	133
2024 Q2	$353K	Sell	23,170 -925	-4%	-$13.3K	0.06%	131
2024 Q1	$353K	Sell	24,095 -2,625	-10%	-$38.3K	0.06%	135
2023 Q4	$372K	Sell	26,720 -560	-2%	-$7.49K	0.07%	130
2023 Q3	$365K	Sell	27,280 -2,395	-8%	-$32.4K	0.08%	126
2023 Q2	$375K	Hold	29,675	–	–	0.08%	128
2023 Q1	$338K	Hold	29,675	–	–	0.08%	135
2022 Q4	$307K	Hold	29,675	–	–	0.07%	147
2022 Q3	$311K	Sell	29,675 -2,180	-7%	-$23.2K	0.08%	136
2022 Q2	$353K	Hold	31,855	–	–	0.09%	131
2022 Q1	$355K	Hold	31,855	–	–	0.08%	142
2021 Q4	$417K	Sell	31,855 -900	-3%	-$11.3K	0.09%	128
2021 Q3	$427K	Sell	32,755 -3,520	-10%	-$46.9K	0.1%	125
2021 Q2	$505K	Buy	36,275 +575	+2%	+$8.04K	0.15%	104
2021 Q1	$438K	Sell	35,700 -350	-1%	-$4.5K	0.1%	132
2020 Q4	$514K	Sell	36,050 -225	-0.6%	-$3.03K	0.13%	115
2020 Q3	$505K	Sell	36,275 -15,530	-30%	-$185K	0.15%	104
2020 Q2	$549K	Sell	51,805 -3,825	-7%	-$38.9K	0.17%	103
2020 Q1	$449K	Sell	55,630 -8,255	-13%	-$68.8K	0.15%	111
2019 Q4	$518K	Sell	63,885 -770	-1%	-$6.08K	0.15%	112
2019 Q3	$490K	Hold	64,655	–	–	0.15%	110
2019 Q2	$485K	Sell	64,655 -380	-0.6%	-$2.99K	0.15%	112
2019 Q1	$527K	Hold	65,035	–	–	0.17%	109
2018 Q4	$490K	Hold	65,035	–	–	0.18%	104
2018 Q3	$450K	Hold	65,035	–	–	0.14%	123
2018 Q2	$419K	Sell	65,035 -3,300	-5%	-$20.8K	0.14%	124
2018 Q1	$447K	Buy	68,335 +3,300	+5%	+$23.1K	0.14%	130
2017 Q4	$489K	Sell	65,035 -800	-1%	-$5.76K	0.16%	120
2017 Q3	$470K	Sell	65,835 -625	-0.9%	-$4.49K	0.16%	123
2017 Q2	$560K	Sell	66,460 -4,400	-6%	-$35.8K	0.21%	107
2017 Q1	$569K	Sell	70,860 -9,725	-12%	-$84K	0.23%	102
2016 Q4	$730K	Sell	80,585 -1,000	-1%	-$9.31K	0.32%	89
2016 Q3	$757K	Sell	81,585 -1,275	-2%	-$12.2K	0.35%	83
2016 Q2	$849K	Hold	82,860	–	–	0.38%	72
2016 Q1	$749K	Sell	82,860 -550	-0.7%	-$4.92K	0.34%	79
2015 Q4	$772K	Sell	83,410 -1,650	-2%	-$18.1K	0.35%	76
2015 Q3	$1.09M	Sell	85,060 -725	-0.8%	-$9.01K	0.52%	52
2015 Q2	$949K	Sell	85,785 -240	-0.3%	-$2.65K	0.4%	73
2015 Q1	$982K	Sell	86,025 -1,875	-2%	-$19.9K	0.41%	72
2014 Q4	$887K	Buy	87,900 +525	+0.6%	+$5.53K	0.38%	74
2014 Q3	$918K	Hold	87,375	–	–	0.42%	73
2014 Q2	$754K	Sell	87,375 -23,225	-21%	-$195K	0.35%	91
2014 Q1	$971K	Sell	110,600 -6,475	-6%	-$56.3K	0.46%	70
2013 Q4	$961K	Sell	117,075 -1,125	-1%	-$8.9K	0.46%	66
2013 Q3	$893K	Sell	118,200 -125	-0.1%	-$909	0.45%	72
2013 Q2	$895K	Buy	+118,325	New	+$864K	0.49%	64

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

FRA

Frank Rimerman Advisors Palo Alto, California $1.77B AUM 41.18% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hanson & Doremus Investment Management's RDY Position: Q2 2026 in Review

Hanson & Doremus Investment Management held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 15,161 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #198.

Hanson & Doremus Investment Management first reported a position in RDY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.09M in Q3 2015. 63 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Hanson & Doremus Investment Management held 15,161 shares of Dr. Reddy's Laboratories worth $220K as of Q2 2026.
Hanson & Doremus Investment Management left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up 0.02% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #198 holding.
Hanson & Doremus Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 53 quarters since.
Hanson & Doremus Investment Management's Dr. Reddy's Laboratories position peaked at $1.09M in Q3 2015.
63 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.